Strategic Wealth Management »

Crispr Therapeutics shares owned by Strategic Wealth Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Strategic Wealth Management from 13F filings

Historical chart of Strategic Wealth Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Strategic Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Strategic Wealth Management

Quarter filed Position value Share count Share price at filing
2021-12-31 $1.1M 14k 75.77
2021-09-30 $824k 7.4k 111.96

More positions owned by Strategic Wealth Management

Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Fs Kkr Capital Corp (FSK)
First Tr Exchange Traded Consumr Staple (FXG)
First Tr Exchange-traded Dj Internt Idx (FDN)
Spdr Gold Tr Gold Shs (GLD)
Exchange Traded Concepts Tr Emqq Em Intern (EMQQ)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Pimco Dynamic Income SHS (PDI)
Global X Fds Cloud Computng (CLOU)
Osi Etf Tr Oshs Gbl Inter
Ishares Tr Rus Mdcp Val Etf (IWS)
Ishares Tr U.s. Med Dvc Etf (IHI)
First Tr Exchange-traded First Tr Enh New (FTSM)
Advanced Micro Devices (AMD)

View all positions for Strategic Wealth Management

Top funds holding Crispr Therapeutics

Capital Research and Management Company - Division 3
ARK Investment Management
State Street Corporation
Nikko Asset Management Americas
BlackRock
Sumitomo Mitsui Trust Holdings
T. Rowe Price Investment Management
FMR
Vanguard Group
NEA Management Company
Citadel Advisors
EcoR1 Capital
Susquehanna International
Bank of America Corporation
Sr One Capital Management

View all funds holding Crispr Therapeutics